Screening and construction of probiotic strains with enhanced protective properties against intestinal disorders

Microbial Ecology in Health and Disease

Volumn 16, Issue 2-3, 2004, Pages 86-95

  Mercenier, Annick ^a,i   Hols, P ^b   Roussel, Y ^c   Perez Martinez, G ^d   Buesa, J ^e   Wilks, M ^c   Pozzi, G ^f   Remaut, E ^g   Morelli, L ^h   Grangette, C ^a   Monedero, V ^d   Palumbo, E ^b   Foligne, B ^a   Steidler, L ^g,j   Nutten, S ^a,i  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

^f UNIVERSITY OF SIENA   (Italy)

^g GHENT UNIVERSITY   (Belgium)

^h UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

ⁱ NESTLÉ RESEARCH CENTER   (Switzerland)

^j UNIVERSITY COLLEGE CORK   (Ireland)

more..

Author keywords

Helicobacter pylori; Immune modulation; Inflammatory bowel disease; Probiotics; Rotavirus

Indexed keywords

INTERLEUKIN 10; PROBIOTIC AGENT;

ANTIINFLAMMATORY ACTIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM MUTANT; CLINICAL TRIAL; COLITIS; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SCREENING; DRUG SYNTHESIS; ENTERITIS; ENTEROPATHY; EPITHELIUM CELL; HELICOBACTER; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INTESTINE EPITHELIUM; LACTOBACILLUS PLANTARUM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ROTAVIRUS; WILD TYPE;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI; LACTOBACILLUS; LACTOBACILLUS PLANTARUM; MURINAE; ROTAVIRUS;

EID: 3342938453     PISSN: 0891060X     EISSN: None     Source Type: Journal    
DOI: 10.1080/08910600410033258     Document Type: Conference Paper

References (33)

1. Mercenier A, Pavan S, Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 2003; 9: 175-91.
2. Fernandez MF, Boris S, Barbes C. Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J Appl Microbiol 2003; 94: 449-55.
3. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002; 168: 171-8.
4. Hershberg RM, Mayer LF. Antigen processing and presentation by intestinal epithelial cells-polarity and complexicity. Immunol Today 2000; 21: 123-8.
5. Haller D, Bode C, Hammes WP, Pfeifer AM, Schiffrin EJ, Blum S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leukocyte co-cultures. Gut 2000; 47: 79-87.
6. Wallace JL, MacNaughton WK, Morris G, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989; 96: 29-36.
7. Neurath M, Fuss I, Strober W. TNBS-colitis. Int Rev Immunol 2000; 19: 51-62.
8. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000; 289: 1352-5.
9. van Deventer SJ, Elson CO, Fedorak RN. Multiple doses of intravenous interleukin-10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology 1997; 113: 383-9.
10. Marteau P, Seksik P, Jian R. Probiotics and health: new facts and ideas. Curr Opin Biotechnol 2002; 13: 486-9.
11. Waterfield NR, Le Page RW, Wilson PW, Wells JM. The isolation of lactococcal promoters and their use in investigating bacterial luciferase synthesis in Lactococcus lactis. Gene 1995; 165: 9-15.
12. van Asseldonk M, Rutten G, Oteman M, Siezen RJ, de Vos WM, Simons G. Cloning of usp-45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363. Gene 1990; 95: 155-60.
13. Lebourgeois P, Lautier M, Vandenberghe L, Gasson MJ, Ritzenthaler P. Physical and genetic-map of the Lactococcus lactis subsp. cremoris MG1363 chromosome - comparison with that of Lactococcus lactis subsp. lactis IL-1403 reveals a large genome inversion. J Bacteriol 1995; 177: 2840-50.
14. Steidler L, Neirynck S, Huyghebaert N, Snoeck V, Vermeire A, Goddeeris B, et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nature Biotechnol 2003; 21: 785-9.
15. Cohen SS, Barner HD. Studies on the unbalanced growth in Escherichia coli. Proc Natl Acad Sci USA 1954; 40: 885-93.
16. Mukhopadhyay P. Gastric cancer and lymphoma. Curr Top Microbiol Immunol 1999; 241: 57-61.
17. Michetti P, Svennerholm AM. Helicobacterpylori - inflammation, immunity and vaccines. Helicobacter 2003; 8(Suppl 1): 31-5.
18. Sachs G, Weeks DL, Melchers K, Scott DR. The gastric biology of Helicobacter pylori. Annu Rev Physiol 2003; 65: 349-69.
19. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997; 112: 1386-97.
20. Wells JM, Mercenier A. Lactic acid bacteria as mucosal delivery system. In: Wood BJB, Warner PJ, eds. Genetics of Lactic Acid Bacteria, 2003: 261-90.
21. Miller MA, McCann L. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus in national immunization schedules. Health Economics 2000; 9: 19-36.
22. Offit PA, Hoffenberg EJ, Santos N, Gouvea V. Rotavirus-specific humoral and cellular immune response after primary, symptomatic infection. J Infect Dis 1993; 157: 1436-40.
23. Gil MT, De Souza CO, Asensi M, Buesa J. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein. Viral Immunol 2000; 13: 187-200.
24. Kapikian AZ, Chanock RM. Rotaviruses. In: Fields BN, Knipe DN, Howley PM, Chanock RM, Melnick JL, Monath TP, et al, eds. Virology, vol. 2. New York: Raven Press, 1996: 1657-708.
25. Ward RL. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. Viral Immunol 2003; 16: 17-24.
26. Schotte L, Steidler L, Vandekerckhove J, Remaut E. Secretion of biologically active murine interleukin-10 by Lactococcus lactis. Enzyme Microb Technol 2000; 27: 761-5.
27. Boot HJ, Kolen CP, Pouwels PH. Interchange of the active and silent S-layer protein genes of Lactobacillus acidophilus by inversion of the chromosomal slp segment. Mol Microbiol 1996; 21: 799-809.
28. Manganelli R, Provvedi R, Berneri C, Oggioni MR, Pozzi G. Insertion vectors for construction of recombinant conjugative transposons in Bacillus subtilis and Enterococcus faecalis: FEMS Microbiol Lett 1998; 168: 259-68.
29. Neuhaus FC, Baddiley J. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol Mol Biol Rev 2003; 67: 686-723.
30. Palumbo E, Favier C, Deghorain M, Cocconcelli PS, Grangette C, Mercenier A, et al. Knockout of the alanine racemase gene in Lactobacillus plantarum results in septation defects and cell wall perforation. FEMS Microbiol Lett 2004; 233: 131-8.
31. Kleerebezem M, Boekhorst J, Van Kranenburg R, Molenaar D, Kuipers OP, Leer R, et al. Complete genome sequence of Lactobacillus plantarum WCFS1. Proc Natl Acad Sci USA 2003; 100: 1990-5.
32. Grangette C, Müller-Alouf H, Hols P, Goudercourt D, Delcour J, Turneer M, Mercenier A. Enhanced mucosal delivery of antigen with cell-wall mutants of lactic acid bacteria. Infect Immun 2004; 72: 2731-7.
33. Cesena C, Morelli L, Alander M, Siljander T, Satokari R, Mattila-Sandholm T, et al. Lactobacillus crispatus and its non-aggregating mutant in human colonization trials. J Dairy Sci 2001; 84: 1001-10.